Angela Flores

796 total citations
7 papers, 344 citations indexed

About

Angela Flores is a scholar working on Clinical Biochemistry, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine. According to data from OpenAlex, Angela Flores has authored 7 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Clinical Biochemistry, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Angela Flores's work include Bacterial Identification and Susceptibility Testing (3 papers), Streptococcal Infections and Treatments (3 papers) and Neonatal and Maternal Infections (3 papers). Angela Flores is often cited by papers focused on Bacterial Identification and Susceptibility Testing (3 papers), Streptococcal Infections and Treatments (3 papers) and Neonatal and Maternal Infections (3 papers). Angela Flores collaborates with scholars based in United States, Netherlands and Spain. Angela Flores's co-authors include James Versalovic, Mariska Leeflang, Mohan Pammi, Elliot M. Frohman, Donna Graves, Benjamin Greenberg, Mohan Pammi Venkatesh, Ruth Ann Luna, Teresa C. Frohman and Wanda Castro-Borrero and has published in prestigious journals such as PEDIATRICS, Cochrane Database of Systematic Reviews and JAMA Neurology.

In The Last Decade

Angela Flores

6 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Flores United States 5 139 116 105 89 51 7 344
Wen-Wei Hsu Taiwan 9 43 0.3× 45 0.4× 60 0.6× 12 0.1× 6 0.1× 15 382
Erdinç Aydın Türkiye 15 161 1.2× 35 0.3× 50 0.5× 14 0.2× 7 0.1× 38 578
Nobuaki Takeda Japan 9 132 0.9× 60 0.5× 15 0.1× 25 0.3× 14 0.3× 21 542
D.F. Archer United States 7 62 0.4× 82 0.7× 14 0.1× 36 0.4× 8 0.2× 21 383
Marco Mattioli Italy 10 16 0.1× 54 0.5× 29 0.3× 88 1.0× 25 0.5× 16 418
Bita Manzouri United Kingdom 11 153 1.1× 31 0.3× 24 0.2× 63 0.7× 3 0.1× 25 332
Grace K. Kim United States 10 22 0.2× 43 0.4× 85 0.8× 106 1.2× 2 0.0× 14 398
Jee Yun Kim South Korea 9 198 1.4× 17 0.1× 31 0.3× 322 3.6× 8 0.2× 12 449
Xingming Zhong China 12 58 0.4× 8 0.1× 98 0.9× 76 0.9× 5 0.1× 39 366
A. P. Iori Italy 8 38 0.3× 14 0.1× 43 0.4× 27 0.3× 20 0.4× 14 245

Countries citing papers authored by Angela Flores

Since Specialization
Citations

This map shows the geographic impact of Angela Flores's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Flores with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Flores more than expected).

Fields of papers citing papers by Angela Flores

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Flores. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Flores. The network helps show where Angela Flores may publish in the future.

Co-authorship network of co-authors of Angela Flores

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Flores. A scholar is included among the top collaborators of Angela Flores based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Flores. Angela Flores is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Andrés, Paloma Jimena de, et al.. (2024). Histological Assessment of Respiratory Tract and Liver of BALB/c Mice Nebulized with Tocilizumab. Pharmaceutics. 16(7). 862–862.
2.
Zhang, Yinan, et al.. (2018). Asymptomatic progressive multifocal leukoencephalopathy: a case report and review of the literature. Journal of Medical Case Reports. 12(1). 187–187. 4 indexed citations
3.
Pammi, Mohan, Angela Flores, James Versalovic, & Mariska Leeflang. (2017). Molecular assays for the diagnosis of sepsis in neonates. Cochrane Database of Systematic Reviews. 2017(2). CD011926–CD011926. 37 indexed citations
4.
Ireland, Sara, Benjamin Greenberg, Angela Flores, et al.. (2014). The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis. JAMA Neurology. 71(11). 1421–1421. 64 indexed citations
5.
Castro-Borrero, Wanda, Donna Graves, Teresa C. Frohman, et al.. (2012). Current and emerging therapies in multiple sclerosis: a systematic review. Therapeutic Advances in Neurological Disorders. 5(4). 205–220. 105 indexed citations
6.
Pammi, Mohan, Angela Flores, Mariska Leeflang, & James Versalovic. (2011). Molecular Assays in the Diagnosis of Neonatal Sepsis: A Systematic Review and Meta-analysis. PEDIATRICS. 128(4). e973–e985. 83 indexed citations
7.
Venkatesh, Mohan Pammi, Angela Flores, Ruth Ann Luna, & James Versalovic. (2010). Molecular microbiological methods in the diagnosis of neonatal sepsis. Expert Review of Anti-infective Therapy. 8(9). 1037–1048. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026